Director Roger Jeffs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rhenman & Partners Asset Management AB Buys 39,000 Shares of Axsome Therapeutics, Inc (NASDAQ:AXSM)

Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […]

United statesRoger jeffsMarkl jacobsonAxsome therapeutics incWashington trust advisors incSg americas securitiesCantor fitzgeraldRoyal bankSecurities exchange commissionMorgan stanleyPartners asset managementAxsome therapeuticsFree reportTrust advisorsIvy capital managementAigen investment management

Axsome Therapeutics, Inc (NASDAQ:AXSM) Stake Boosted by Meridian Wealth Management LLC

Meridian Wealth Management LLC raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,498 shares of the company’s stock after purchasing an additional 1,275 shares during […]

United statesRoger jeffsMarkl jacobsonRobertw bairdMeridian wealth managementExchange commissionWashington trust advisors incCantor fitzgeraldFifth third bancorpAxsome therapeutics company profileMorgan stanleyAxsome therapeutics incThird bancorpSg americas securitiesRoyal bankAxsome therapeutics

Axsome Therapeutics, Inc (NASDAQ:AXSM) Given Average Recommendation of Moderate Buy by Analysts

Axsome Therapeutics, Inc (NASDAQ:AXSM) Given Average Recommendation of Moderate Buy by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandUnited statesRobertw bairdMarkl jacobsonRoger jeffsAxsome therapeutics incPhocas financial corpWellington management groupVictory capital management incSecurities exchange commissionKennedy capital managementRoyal bankAxsome therapeuticsGet free reportMarketbeat ratings

Axsome Therapeutics (NASDAQ:AXSM) Given New $106 00 Price Target at Mizuho

Axsome Therapeutics (NASDAQ:AXSM) Given New $106 00 Price Target at Mizuho
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRoger jeffsPiper sandlerMarkl jacobsonSecurities exchange commissionCovestor ltdRussell investments group ltdAxsome therapeutics incWashington trust advisors incCantor fitzgeraldFifth third bancorpThird bancorpChina universal asset management coRoyal bankAxsome therapeuticsFree report

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112 00

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdRoger jeffsMarkl jacobsonSecurities exchange commissionAxsome therapeutics company profileRussell investments group ltdCantor fitzgeraldMorgan stanleyAxsome therapeutics incWashington trust advisors incThird bancorpFifth third bancorpChina universal asset management coJaniczek wealth managementAxsome therapeutics